The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

NCT00859768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 568

Last updated 2011-03-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and feasibility of the Screening Inventory of Psychosocial Problems (SIPP) in consultation settings with respect to early recognition and treatment of psychosocial distress, communication between patients and physicians, and psychological distress and quality of life in cancer patients treated with radiotherapy (RT).

Conditions

Interventions

OTHER

Questionnaire administration

The patient receives the SIPP at two different time points during their RT period. The first time point is before the first consultation with the radiotherapist (before starting RT) and the second time point is before the last consultation with the radiotherapist at the end of the RT period. At both time points, the SIPP is handed over to the radiotherapist at the start of the consultation. The radiotherapist screens the scores of the SIPP to get an overview of potential psychosocial problems and patient's needs of psychosocial care.

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • Institute Verbeeten

    collaborator OTHER
  • Maastro Clinic, The Netherlands

    collaborator OTHER
  • Netherlands Open University

    lead OTHER

Principal Investigators

  • Lilian Lechner, PhD · Netherlands Open University, Faculty of Psychology

  • Gertrudis I Kempen, PhD · Maastricht University, Faculty of Health, Medicine, and life Sciences, Department of Health Care and Nursing Science, School for Public Health and Primary Care (CAPHRI)

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00859768 on ClinicalTrials.gov